Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.5K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.5K
Bone Remodeling01:40

Bone Remodeling

39.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
39.1K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

3.3K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.3K
Bone Disorders01:29

Bone Disorders

4.6K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Roles of Del-1 in effects of hyponatremia on muscle and bone in mice.

Bone·2026
Same author

Systemic administration of osteoblast-derived collagenase released extracellular vesicles restores trabecular bone loss in ovariectomized mice.

Bone·2026
Same author

Tmem119 is involved in the bone repair enhanced by parathyroid hormone in female mice.

The Journal of endocrinology·2026
Same author

Prevalence and association of sarcopenic obesity with locomotive syndrome based on the 2024 Consensus Statement of the Japanese Working Group on Sarcopenic Obesity in community-dwelling Japanese women.

Journal of physical therapy science·2025
Same author

The role of Tmem119 in the estrogen action on bone in mice.

Journal of bone and mineral metabolism·2025
Same author

Roles of plasminogen activator inhibitor-1 in aging-related muscle and bone loss in mice.

Aging·2025

Related Experiment Video

Updated: Nov 5, 2025

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

6.7K

Serpinb1a suppresses osteoclast formation.

Masayoshi Ishida1, Naoyuki Kawao1, Yuya Mizukami1

  • 1Department of Physiology and Regenerative Medicine, Kindai University Faculty of Medicine, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan.

Biochemistry and Biophysics Reports
|May 17, 2021
PubMed
Summary

Serine protease inhibitor Serpinb1a inhibits osteoclast formation and suppresses osteoblast activity. This study reveals novel roles for Serpinb1a in bone cell differentiation and potential implications for metabolic disorders.

Keywords:
Mechanical stressOsteoblastOsteoclastSerine protease inhibitorSerpinb1

More Related Videos

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.7K
A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

13.7K

Related Experiment Videos

Last Updated: Nov 5, 2025

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

6.7K
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

4.7K
A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

13.7K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Bone Biology

Background:

  • Serine protease inhibitor family protein (Serpinb1a) is linked to immunoregulation and metabolic disorders.
  • The function of Serpinb1a in bone metabolism remains largely unexplored.

Purpose of the Study:

  • To investigate the physiological roles of Serpinb1a in osteoclastic and osteoblastic differentiation.
  • To elucidate the impact of Serpinb1a on key markers of bone cell development.

Main Methods:

  • Utilized mouse preosteoclastic RAW 264.7 and mesenchymal ST2 cell lines.
  • Overexpressed Serpinb1a to assess its effects on osteoclast and osteoblast differentiation.
  • Quantified mRNA levels of specific differentiation markers and enzyme activities.

Main Results:

  • Serpinb1a overexpression inhibited receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclast formation in RAW 264.7 cells.
  • Reduced mRNA levels of nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1), TRAP, and cathepsin K.
  • Suppressed bone morphogenetic protein-2 (BMP-2)-induced alkaline phosphatase (ALP) activity and mRNA levels of ALP and osteocalcin in ST2 cells.

Conclusions:

  • Serpinb1a significantly inhibits osteoclastogenesis.
  • Serpinb1a suppresses osteoblast differentiation markers, particularly in response to BMP-2 stimulation.
  • These findings highlight Serpinb1a as a novel regulator of bone cell function.